Antidepressant Drugs Market By Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, Others), By product (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist and Reuptake Inhibitors, Others)Report ID: BMRC 879 | Number of pages: 197 | Publish Date: Aug 2019 | Publisher: BMRC | Category: Lifesciences and Healthcare
Antidepressant Drugs Market is valued at USD 13.69 Billion in 2018 and expected to reach USD 15.88 Billion by 2025 with the CAGR of 2.15% over the forecast period. Increasing Cases of Mental Health Disorders is driving the Antidepressant Drugs Market.
Scope of Antidepressant Drugs Market Report:Antidepressants are a type of drugs that decreases symptoms of depressive disorders by acting against chemical imbalances of neurotransmitters in brain. Antidepressants drugs are used for treatment of depressive disorder, anxiety disorders, chronic pain conditions and to manage some addictions. Antidepressants have some side effects such as dry mouth, weight gain, dizziness, headaches, sexual dysfunction and sometimes increased thoughts of suicide when taken by children, young adults and adolescents. After stopping antidepressants a discontinuation syndrome can occur and this resembles recurrent depression. There are different classes of antidepressant drugs are available in medical industry, some of them are selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), tetracyclic antidepressant, dopamine reuptake blocker etc. Global antidepressant drugs market report is segmented on the basis of depressive disorder, products, regional & country level. Based upon depressive disorder, global antidepressant drugs market is classified as major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, panic disorder, and others. On the basis of products, the market is segmented in to tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, serotonin antagonist and reuptake inhibitors, and others. The regions covered in this antidepressant drugs market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Antidepressant Drugs is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc. Key Players for Global Antidepressant Drugs Market Reports– Global Antidepressant Drugs market report covers prominent players like Alkermes Plc, Allergan Plc, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck, Eli Lilly and Co., Merck & Co. Inc., Pfizer Inc., and Takeda Pharmaceutical Co. Ltd Teva Pharmaceutical Industries Ltd., AstraZeneca, Johnson & Johnson, and others. Increasing Cases of Mental Health Disorders is driving the Antidepressant Drugs Market Increasing cases of mental health disorders globally is the main factor for the growth of antidepressant drug market, as many consumers are relying on these drugs to fight with the depression, anxiety disorder etc. Globally, the share of population with depression ranges in between 2% to 6% and older people are going through the high risk of depression comparing to other age groups. An estimation of 322 million people was under depression disorder according to WHO till 2015 and many among them are depending on these drugs for medication purpose which helps the antidepressant market to grow. In some of the anxiety disorder cases, antidepressant drugs are used. As it is the most prevalent mental health disorder with around 284 million people suffering from anxiety disorder, this creates more opportunity for the market to grow in this segment. According to the Centre for Disease Control and Prevention (CDC), the percentage of people above age 12 years using antidepressants in USA rose to 12.7% in 2011-2014. The antidepressant drugs are used in disorders such as agitation, obsessive-compulsive disorders (OCD), childhood enuresis, major depressive disorder, generalized anxiety disorder, bipolar disorder, posttraumatic stress disorder (PTSD), social anxiety disorder etc. Antidepressant drug are also used in off-label cases such as insomnia, pain and migraine. Almost 29% of antidepressant drugs are used for off-label purpose. Side effects during the medication of these drugs are the main restraining factor for antidepressant drugs market. Report evaluates the growth rate and the Market value based on Market dynamics, growth inducing factors. The complete knowledge is based on latest industry news, opportunities and trends. The report contains a comprehensive Market analysis and vendor landscape in addition to a SWOT analysis of the key vendors. Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Antidepressant Drugs Market. Key Benefits for Antidepressant Drugs Market Reports • Global market report covers in-depth historical and forecast analysis. • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level. • Global market report helps to identify opportunities in market place. • Global market report covers extensive analysis of emerging trends and competitive landscape.
Global Antidepressant Drugs Market Segmentation –By Depressive Disorder: • Major Depressive Disorder • Obsessive-Compulsive Disorder • Generalized Anxiety Disorder • Panic Disorder • Others By product • Tricyclic Antidepressants • Selective Serotonin Reuptake Inhibitors • Serotonin-Norepinephrine Reuptake Inhibitors • Monoamine Oxidase Inhibitors • Serotonin Antagonist and Reuptake Inhibitors • Others By Region • North America o U.S. o Canada o Mexico • Europe o UK o France o Germany o Russia o Rest of Europe • Asia-Pacific o China o South Korea o India o Japan o Rest of Asia-Pacific • LAMEA o Latin America o Middle East o Africa North America is dominating the Antidepressant Drugs Market North America is dominating the antidepressant market due to wide use of drugs among people and large number of prescriptions along with rising disorder cases. In USA, antidepressants were the most commonly prescribed drugs in 2013 and from over 16 million long term users, around 70% are female. In Europe the antidepressant drug market is growing due to increasing number of cases along with long duration of drug treatment. For example, in England and France, the rise in antidepressants consumption has been associated with a longer duration of drug treatment. Iceland recorded the highest level of antidepressant drug consumption in 2013 with almost high prescription rate. Asia pacific region is experiencing considerable growth rate in antidepressant drugs market due to increasing awareness of treatment procedures. According to WHO, South East Asia region have more than 86 million people who are suffering from depression. Barriers for the antidepressant drugs market in Asia Pacific region is lack of resources and trained health-care providers. For example, on an average less than 1% of government health budget is invested in mental health. Antidepressant Drugs Market Key Players: • Alkermes Plc • Allergan Plc • Bristol Myers Squibb Co. • Eli Lilly and Co. • GlaxoSmithKline Plc • H. Lundbeck • Eli Lilly and Co. • Merck & Co. Inc. • Pfizer Inc. • Takeda Pharmaceutical Co. Ltd • Teva Pharmaceutical Industries Ltd. • AstraZeneca • Johnson & Johnson • Other This comprehensive report will provide: • Enhance your strategic decision making • Assist with your research, presentations and business plans • Show which emerging market opportunities to focus on • Increase your industry knowledge • Keep you up-to-date with crucial market developments • Allow you to develop informed growth strategies • Build your technical insight • Illustrate trends to exploit • Strengthen your analysis of competitors • Provide risk analysis, helping you avoid the pitfalls other companies could make • Ultimately, help you to maximize profitability for your company. Our Market Research Solution Provides You Answer to Below Mentioned Question: • Which are the driving factors responsible for the growth of market? • Which are the roadblock factors of this market? • What are the new opportunities, by which market will grow in coming years? • What are the trends of this market? • Which are main factors responsible for new product launch? • How big is the global & regional market in terms of revenue, sales and production? • How far will the market grow in forecast period in terms of revenue, sales and production? • Which region is dominating the global market and what are the market shares of each region in the overall market in 2017? • How will each segment grow over the forecast period and how much revenue will these segment account for in 2025? • Which region has more opportunities?
Table of Content 1. Chapter - Report Methodology 1.1. Research Process 1.2. Primary Research 1.3. Secondary Research 1.4. Market Size Estimates 1.5. Data Triangulation 1.6. Forecast Model 1.7. USP’s of Report 1.8. Report Description 2. Chapter – Global Antidepressant Drugs Market Overview: Qualitative Analysis 2.1. Market Introduction 2.2. Executive Summary 2.3. Global Antidepressant Drugs Market Classification 2.4. Market Drivers 2.5. Market Restraints 2.6. Market Opportunity 2.7. Antidepressant Drugs Market: Trends 2.8. Porter’s Five Forces Analysis 2.8.1. Bargaining Power of Suppliers 2.8.2. Bargaining Power of Consumers 2.8.3. Threat of New Entrants 2.8.4. Threat of Substitute Product and Services 2.8.5. Competitive Rivalry within the Industry 2.9. Market Attractiveness Analysis 2.9.1. Market Attractiveness Analysis by Segmentation 2.9.2. Market Attractiveness Analysis by Region 3. Chapter - Global Antidepressant Drugs Market Overview: Quantitative Analysis 3.1. Global Antidepressant Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025 3.2. Global Antidepressant Drugs Market Revenue Market Share (%), 2014- 2025 3.3. Global Antidepressant Drugs Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025 3.4. Global Antidepressant Drugs Market Sales Market Share (%), 2014- 2025 4. Chapter – Global Antidepressant Drugs Market Analysis: By Product Type 5. Chapter – Global Antidepressant Drugs Market Analysis: By Depressive Disorder 6. Chapter – Global Antidepressant Drugs Market Analysis: By End-User 7. Chapter - Global Antidepressant Drugs Market Analysis: By Manufacturer 7.1. Global Antidepressant Drugs Market Revenue (USD Million), by Manufacturer, 2014 - 2025 7.2. Global Antidepressant Drugs Market Share (%), by Manufacturer, 2018 7.3. Global Antidepressant Drugs Market Sales (Number of Units), by Manufacturer, 2014 - 2025 7.4. Global Antidepressant Drugs Market Share (%), by Manufacturer, 2018 7.5. Global Antidepressant Drugs Market Price (USD/Unit), by Manufacturer, 2014 - 2025 7.6. Global Antidepressant Drugs Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025 7.7. Merger & Acquisition 7.8. Collaborations and Partnership 7.9. New Product Launch 8. Chapter –Antidepressant Drugs Market: Regional Analysis 8.1. North America 8.1.1. North America Antidepressant Drugs Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025. 8.1.2. North America Antidepressant Drugs Market Revenue (USD Million) By Country, 2014 – 2025. 8.1.3. North America Antidepressant Drugs Revenue Market Share (%) By Country, 2014 – 2025. 8.1.4. North America Antidepressant Drugs Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025. 8.1.5. North America Antidepressant Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025. 8.1.6. North America Antidepressant Drugs Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025. 8.1.7. North America Antidepressant Drugs Market Sales (Number of Units) By Country, 2014 – 2025. 8.1.8. North America Antidepressant Drugs Sales Market Share (%) By Country, 2014 – 2025. 8.1.9. North America Antidepressant Drugs Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025. 8.1.10. North America Antidepressant Drugs Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025. 8.2. Europe 8.3. Asia Pacific 8.4. Latin America 8.5. Middle East & Africa 9. Chapter - Company Profiles 9.1. Alkermes Plc 9.2. Fluke Calibration 9.2.1. Financials 9.2.2. Product portfolio 9.2.3. Antidepressant Drugs Market Revenue (USD Million) and Market Share (%), 2014 - 2018 9.2.4. Antidepressant Drugs Sales Market Share (%), 2014 - 2018 9.2.5. Business strategy 9.2.6. Recent developments 9.3. Alkermes Plc 9.4. Allergan Plc 9.5. Bristol Myers Squibb Co. 9.6. Eli Lilly and Co. 9.7. GlaxoSmithKline Plc 9.8. H. Lundbeck 9.9. Eli Lilly and Co. 9.10. Merck & Co. Inc. 9.11. Pfizer Inc. 9.12. Takeda Pharmaceutical Co. Ltd 9.13. Teva Pharmaceutical Industries Ltd. 9.14. AstraZeneca 9.15. Johnson & Johnson 9.16. Others 10. Chapter – Market Research and Findings
This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.